세계의 지카바이러스 검사 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향 및 예측(2025-2032년)

Persistence Market Research has recently published an in-depth report on the global Zika Virus Testing Market, offering detailed insights into current trends, growth drivers, market challenges, and emerging opportunities. This report serves as a strategic guide for industry stakeholders looking to navigate the evolving landscape of infectious disease diagnostics and capitalize on market potential.

Key Insights:

• Zika Virus Testing Market Size (2025E): US$ 5.1 Mn
• Projected Market Value (2032F): US$ 6.9 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 4.3%

Zika Virus Testing Market - Report Scope:

The Zika virus testing market involves a range of diagnostic techniques used to detect the Zika virus, including molecular and serological tests. These tests are crucial for early diagnosis, prenatal care, and outbreak control. The market is witnessing steady growth, driven by rising health awareness, technological advancements in diagnostics, and ongoing efforts by global health organizations to improve disease detection capabilities. As concerns around birth defects and the virus's impact on pregnant women continue, the need for accurate and accessible testing remains high.

Market Growth Drivers:

The growth of the Zika virus testing market is supported by increasing awareness of the virus's severe health implications, especially during pregnancy. Growing international travel and climate changes have contributed to the wider spread of Zika-carrying mosquitoes, boosting the demand for reliable testing. Technological advancements in diagnostics, such as rapid molecular testing and improved serological assays, have significantly enhanced detection speed and accuracy. Additionally, funding from global health authorities and proactive government health policies are playing a vital role in expanding testing infrastructure and capabilities worldwide.

Market Restraints:

While the market shows growth potential, certain factors are limiting its expansion. A notable decline in reported Zika cases in recent years has reduced testing urgency, particularly in non-endemic regions. High testing costs, especially for molecular diagnostics, pose a barrier in low-income countries. Inadequate healthcare infrastructure and a lack of trained professionals in rural areas also restrict the widespread adoption of Zika testing. Furthermore, competition from multi-disease diagnostic platforms and shifting healthcare priorities may divert focus away from Zika-specific testing services.

Market Opportunities:

Significant opportunities exist in the development of portable, rapid, and cost-effective testing solutions tailored for remote and underserved regions. The growing focus on maternal health and prenatal screening programs presents strong demand for Zika virus diagnostics. Advances in point-of-care testing and multiplex assays that detect multiple infections simultaneously are also opening up new applications. Emerging economies, with increased healthcare investment and support from global agencies, represent untapped markets. Collaborations between diagnostic companies and public health organizations can further enhance test availability and drive innovation in Zika diagnostics.

Key Questions Answered in the Report:

• What factors are contributing to the global demand for Zika virus testing?
• Which testing methods and applications are expected to see the highest growth?
• How are diagnostic innovations influencing the Zika testing market?
• Who are the major players, and what strategies are they implementing?
• What regional developments are shaping the future of the Zika virus testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the Zika virus testing space, including Abbott Laboratories, Chembio Diagnostics Inc., and Roche, are prioritizing the development of rapid, user-friendly, and affordable diagnostic kits. These players are expanding their market reach through strategic partnerships with public health organizations and increased presence in emerging markets. Emphasis is placed on creating scalable solutions that can be deployed during outbreaks or used in routine prenatal screening. By enhancing product efficiency and focusing on underserved regions, key companies are positioning themselves to lead the market as global health priorities evolve.

Companies Covered in This Report:

• Abbott Laboratories
• Altona Diagnostics GmbH
• Chembio Diagnostics Inc.
• ELITechGroup
• Hoffmann-La Roche Ltd
• Genekam
• DiaSorin (Luminex Corporation)
• Novacyt Group

Market Segmentation

By Test Type

• Molecular Testing
• Serological Testing

By Application

• Clinical Testing
• Blood Screening
• Research and Development
• Prenatal Testing

By End-use

• Hospitals and Clinics
• Diagnostic Laboratories
• Blood Banks
• Research Institutes
• Public Health Organizations

By Region

• North America
• Europe
• East Asia
• Middle East & Africa
• Latin America
• South Asia & Pacific

Table of Contents

1. Executive Summary

• 1.1. Global Zika Virus Testing Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-economic Factors
  • 2.3.1. Global Sectoral Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Tool Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Deployment Costs
• 4.3. Pricing Analysis, By Application

5. Global Zika Virus Testing Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 5.3. Global Zika Virus Testing Market Outlook: Test Type
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Test Type, 2019-2024
  • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 5.3.3.1. Molecular Testing
    • 5.3.3.2. Serological Testing
  • 5.3.4. Market Attractiveness Analysis: Test Type
• 5.4. Global Zika Virus Testing Market Outlook: Application
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 5.4.3.1. Clinical Testing
    • 5.4.3.2. Blood Screening
    • 5.4.3.3. Research and Development
    • 5.4.3.4. Prenatal Testing
  • 5.4.4. Market Attractiveness Analysis: Application
• 5.5. Global Zika Virus Testing Market Outlook: End User
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 5.5.3.1. Hospitals and Clinics
    • 5.5.3.2. Diagnostic Laboratories
    • 5.5.3.3. Bloods Banks
    • 5.5.3.4. Research Institutes
    • 5.5.3.5. Public Health Organizations
  • 5.5.4. Market Attractiveness Analysis: End User

6. Global Zika Virus Testing Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
• 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Zika Virus Testing Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Test Type
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 7.4.1. Molecular Testing
  • 7.4.2. Serological Testing
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.5.1. Clinical Testing
  • 7.5.2. Blood Screening
  • 7.5.3. Research and Development
  • 7.5.4. Prenatal Testing
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Hospitals and Clinics
  • 7.6.2. Diagnostic Laboratories
  • 7.6.3. Bloods Banks
  • 7.6.4. Research Institutes
  • 7.6.5. Public Health Organizations
• 7.7. Market Attractiveness Analysis

8. Europe Zika Virus Testing Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Test Type
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 8.4.1. Molecular Testing
  • 8.4.2. Serological Testing
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.5.1. Clinical Testing
  • 8.5.2. Blood Screening
  • 8.5.3. Research and Development
  • 8.5.4. Prenatal Testing
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Hospitals and Clinics
  • 8.6.2. Diagnostic Laboratories
  • 8.6.3. Bloods Banks
  • 8.6.4. Research Institutes
  • 8.6.5. Public Health Organizations
• 8.7. Market Attractiveness Analysis

9. East Asia Zika Virus Testing Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Test Type
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 9.4.1. Molecular Testing
  • 9.4.2. Serological Testing
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.5.1. Clinical Testing
  • 9.5.2. Blood Screening
  • 9.5.3. Research and Development
  • 9.5.4. Prenatal Testing
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Hospitals and Clinics
  • 9.6.2. Diagnostic Laboratories
  • 9.6.3. Bloods Banks
  • 9.6.4. Research Institutes
  • 9.6.5. Public Health Organizations
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Zika Virus Testing Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Test Type
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 10.4.1. Molecular Testing
  • 10.4.2. Serological Testing
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.5.1. Clinical Testing
  • 10.5.2. Blood Screening
  • 10.5.3. Research and Development
  • 10.5.4. Prenatal Testing
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals and Clinics
  • 10.6.2. Diagnostic Laboratories
  • 10.6.3. Bloods Banks
  • 10.6.4. Research Institutes
  • 10.6.5. Public Health Organizations
• 10.7. Market Attractiveness Analysis

11. Latin America Zika Virus Testing Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Test Type
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 11.4.1. Molecular Testing
  • 11.4.2. Serological Testing
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.5.1. Clinical Testing
  • 11.5.2. Blood Screening
  • 11.5.3. Research and Development
  • 11.5.4. Prenatal Testing
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals and Clinics
  • 11.6.2. Diagnostic Laboratories
  • 11.6.3. Bloods Banks
  • 11.6.4. Research Institutes
  • 11.6.5. Public Health Organizations
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Zika Virus Testing Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Test Type
  • 12.2.3. By Application
  • 12.2.4. By Application
  • 12.2.5. By End User
• 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
  • 12.4.1. Molecular Testing
  • 12.4.2. Serological Testing
• 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 12.5.1. Clinical Testing
  • 12.5.2. Blood Screening
  • 12.5.3. Research and Development
  • 12.5.4. Prenatal Testing
• 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 12.6.1. Hospitals and Clinics
  • 12.6.2. Diagnostic Laboratories
  • 12.6.3. Bloods Banks
  • 12.6.4. Research Institutes
  • 12.6.5. Public Health Organizations
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Abbott Laboratories
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Deployments
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Altona Diagnostics GmbH
  • 13.3.3. Chembio Diagnostics Inc.
  • 13.3.4. ELITechGroup - A Bruker Company
  • 13.3.5. F. Hoffmann La-Roche AG
  • 13.3.6. Genekam Biotechnology AG
  • 13.3.7. DiaSorin (Luminex Corporation)
  • 13.3.8. Novacyt Group

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations